Science Daily reports on InSight Technology on the 29th of January, 2014. The website Science Daily reports on how the InSight Technology has been applied to the studying of the inflammatory process that occurs in the pancreas during type 1 diabetes. Unlike other non-invasive techniques such as PET and MRI, the InSight technology enables in …
Images of the researchers in Professor Per-Olof Berggren’s group were presented an Biomedical Picture of the Day (BPoD) on the 31st of December 2013. BPoD stands for Biomedical Picture of the Day. The website is managed by the MRC Clinical Sciences Centre. It aims to engage everyone in the wonders of biomedicine. Images are provided by the …
InSight Technology was featured in the Research Report section of Wall Street Journal on the 23rd of December 2013 Wall Street Journal reports on the possibility to study molecular and cellular processes in the pancreatic islets by using InSight Technology. The report is published on the 23rd of December 2013 in the Research Report section. …
A possibility to study the islets of Langerhans in a mouse eye is reported by NyTeknik on the 2nd of December 2013. Researchers in P-O Berggren’s group have come with a solution to study diabetes progress and effectiveness of a treatment program and exercising. If one places insulin-producing islets of Langerhans into a mouse eye, …
Swedish daily newspaper DN reports on the possibility to study islets of Langerhans in the eye on the 19th of November 2013. DN presents InSight Technology and its possibilities in an article published on the 19th of November 2013. Islets of Langerhans are placed into a mouse eye. They reflect the processes happening in the islets …
Swedish news channel SVT Vetenskap reports on the InSight Technology on the 19th of November 2013. The islets of Langerhans placed in the mouse eye behave in the same way as the islets in the pancreas. It opens for a possibility to study the progress of diabetes by looking into a patient’s eye. One can …
Swedish Crown Princess Victoria visited Rolf Luft Research Center at KI and Professor P-O Berggren’s group on the 14th of November, the International Diabetes Day. During the visit, the Crown Princess got introduced to diabetes and its complications, as well as to new findings, the research group’s projects and InSight Technology. Read more: Report published …
Professor Per-Olof Berggren has received 4 major distinctions during 2012: Alex Hirsch from Karolinska Institutet, Wallenberg Scholars, The Novo Nordisk Foundation Advanced Grant and Kroc Lecture at Boston University Medical Center. Professor Berggren’s distinctions are for the following achievements: Axel Hirsch Prize from Karolinska Institutet. The prize is for scientific achievements, which are potentially of major significance to the treatment of …
Biocrine’s CEO Professor PO Berggren was interviewed by NyTeknik, Swedish leading technology and IT newspaper. Treating diabetes with transplanted insulin-producing islets of Langerhans was the main subject of the discussion. Transplantation into the eye is a novel method developed by Prof Berggren’s research group. So far, the procedure has been thoroughly tested in mice leading …
On the 28th of October 2011, Biocrine was featured as one of the prominent life science companies on the 92nd annual meeting of IVA. In an interview for IVA, Biocrine’s CEO Per-Olof Berggren talked about the main focus of the research; understanding of how a healthy insulin producing beta cell works, …